Telisotuzumab (Synonyms: ABT-700) |
| Catalog No.GC70006 |
Telisotuzumab (ABT-700) is a humanized recombinant bivalent antibody that targets the hepatocyte growth factor receptor (MET) as a therapeutic antibody. It can bind to c-Met with high affinity and inhibit c-Met signaling. Telisotuzumab has anti-tumor activity.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1781223-80-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Telisotuzumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Telisotuzumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *